'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply
- PMID: 35798145
- PMCID: PMC9250883
- DOI: 10.1016/j.cmi.2022.06.028
'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply
Comment on
-
Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM.Clin Microbiol Infect. 2022 Nov;28(11):1519. doi: 10.1016/j.cmi.2022.06.013. Epub 2022 Jun 20. Clin Microbiol Infect. 2022. PMID: 35738319 Free PMC article. No abstract available.
Similar articles
-
Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM.Clin Microbiol Infect. 2022 Nov;28(11):1519. doi: 10.1016/j.cmi.2022.06.013. Epub 2022 Jun 20. Clin Microbiol Infect. 2022. PMID: 35738319 Free PMC article. No abstract available.
-
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.Clin Microbiol Infect. 2022 Jun;28(6):844-851. doi: 10.1016/j.cmi.2022.02.027. Epub 2022 Mar 5. Clin Microbiol Infect. 2022. PMID: 35259529 Free PMC article. Clinical Trial.
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply.Clin Microbiol Infect. 2021 Aug;27(8):1177-1178. doi: 10.1016/j.cmi.2021.02.024. Epub 2021 Mar 8. Clin Microbiol Infect. 2021. PMID: 33705848 Free PMC article. No abstract available.
-
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials.J Investig Med. 2022 Jan;70(1):55-60. doi: 10.1136/jim-2021-002001. Epub 2021 Sep 24. J Investig Med. 2022. PMID: 34561232 Free PMC article.
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.Clin Microbiol Infect. 2021 Aug;27(8):1076-1082. doi: 10.1016/j.cmi.2021.04.019. Epub 2021 Apr 27. Clin Microbiol Infect. 2021. PMID: 33915284 Free PMC article.
Cited by
-
Complex changes in serum protein levels in COVID-19 convalescents.Sci Rep. 2024 Feb 23;14(1):4479. doi: 10.1038/s41598-024-54534-7. Sci Rep. 2024. PMID: 38396092 Free PMC article.
References
-
- Klopfenstein T., Gendrin V., Zayet S. Re: 'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study’ by Broman et al. Clin Microbiol Infect. 2022 [Epub ahead of print] - PMC - PubMed
-
- Broman N., Feuth T., Vuorinen T., Valtonen M., Hohenthal U., Löyttyniemi E., et al. Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study. Clin Microbiol Infect. 2022;28:844–851. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources